Suresh Agarwal

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Courtney D. DiNardo, Keith W. Pratz, Anthony Letai et al. · The Lancet Oncology · 2018 · 692 citations

Hematological Malignancy, Oncology, Elderly Patients +10

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou et al. · Journal of Clinical Oncology · 2019 · 680 citations · Full text

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto et al. · Blood · 2017 · 517 citations · Full text

Emergency general surgery

Shahid Shafi, Michel B. Aboutanos, Suresh Agarwal et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2013 · 344 citations

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

John F. Seymour, Shuo Ma, Danielle M. Brander et al. · The Lancet Oncology · 2017 · 321 citations · Full text

Phase 1B, Lymphoid Neoplasia, Hematological Malignancy +10